Articles by Disease (Gastric Cancer)

Small-molecule Inhibitors of Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinases (TK)

Journal: Current Pharmaceutical Design
Volume: 9
Page: 567-581
Author(s): Fabrizio Manetti and Maurizio Botta

Apoptosis in Drug Response

Journal: Current Pharmacogenomics
Volume: 1
Page: 9-16
Author(s): Simone Fulda and Klaus-Michael Debatin

Genetic Polymorphism and Tumor Immunotherapy

Journal: Current Pharmacogenomics
Volume: 1
Page: 37-57
Author(s): Rongcun Yang and Richard B.S. Roden

subject Index To Volume 2

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 3
Page: 69-71
Author(s): Bentham Science Publishers

New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3
Page: 119-131
Author(s): Shinji Osada and Shigetoyo Saji

Proteinase-Activated Receptor-2: Physiological and Pathophysiological Roles

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 1
Page: 61-72
Author(s): Anne-Marie Coelho, Valeria Ossovskaya and Nigel W. Bunnett

Protease-Activated Receptor-2 Antagonists and Agonists

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 1
Page: 73-82
Author(s): Robert M. Scarborough

Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy

Journal: Current Drug Targets
Volume: 4
Page: 113-121
Author(s): Joachim Drevs, Michael Medinger, Carmen Schmidt-Gersbach, Renate Weber and Clemens Unger

Current Targets for Anticancer Drug Discovery

Journal: Current Drug Targets
Volume: 4
Page: 159-179
Author(s): Nguyen-Hai Nam and Keykavous Parang

Neuropeptides as Autocrine Growth Factors in Cancer Cells

Journal: Current Pharmaceutical Design
Volume: 9
Page: 495-509
Author(s): Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen